Brand Name: SGONEK
Price: $40 -$65/Kilogram
Place of Origin: Shaanxi, China
Certification: ISO FDA SG COA MSDS
Grade: Feed Grade, Medicine Grade
Payment Terms: T/T, Western Union, MoneyGram
| Product Name: | methylglucamine | Cas No.: | 6284-40-8 |
| Molecular Formula: | C7H17NO5 | Purity: | 99%min |
| Brand Name: | SGONEK | Certification: | ISO FDA SG COA MSDS |
| CAS No. | 6284-40-8 |
| Model Number | SGONEK-methylglucamine |
| Appearance | White Powder |
| Purity | 99%min |
| Siez | 100% Pass 80 Mesh |
| Sample | 1-5g free |
| Test Method | HPLC UV |
| Package | 1KG/Bag,5kg/bag,25kg/bag |
| Certificate | ISO/FDA/S G S/MSDS |
| MOQ | 1KG |
N-methylglucamine is chemically named 1-deoxy-1-(methylamino)-D-sorbitol, a white crystalline powder. The temperature of 128-129 ° C. Soluble in water, slightly soluble in ethanol (1.2g soluble in 100ml ethanol, soluble at 25°C, 21g soluble at 70°C), almost insoluble in chloroform. The taste is slightly sweet and has a salty taste. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-132oC, and the boiling point is 490.4oCoC at 760 mmHg.
Meglumine is an organic base which is mainly used as a pH adjuster and solubilizer in the preparation of a soluble salt of an iodinated organic acid (used as an X-ray contrast agent).
Meglumine is an amino sugar derived from sorbitol. It is often used as an excipient in pharmaceuticals and in conjunction with iodinated compounds in contrast media such as diatrizoate meglumine and iodipamide meglumine.
Meglumine is an antiprotozoal drug for leischmaniasis.
| Items | Specification | Results |
| Appearance | White powder | complies |
| Identification | Positive reaction | complies |
| Melting point | 128 ~ 132 ℃ | 128 ~ 130 ℃ |
| Clarity and color of the solution | The solution is clear | complies |
| Loss on drying | ≤1.0% | 0.08% |
| Residue on ignition | ≤0.1% | 0.04% |
| Heavy metals | ≤0.002% | complies |
| Specific rotation | -15.7 ~ -17.3 º | -16.4º |
| Reducing substances | Conform to the requirement | complies |
| Absorbance (420nm) | ≤0.03 (20w/v) | 0.007 |
| Assay | 99.0 ~ 100.5% (on dry) | 99.50% |
1. Meglumine can enhance the liposoluble property of cyclic adenosine monophosphate and increase the purity of cyclic adenosine monophosphate to maximize its pharmacological action.
2. Meglumine has positive inotropic effect and is a non-digitalis cardiotonic drug, which can enhance myocardial contractility and improve heart pumping function.
3. It has a vasodilator effect, expands the peripheral blood vessels, and reduces the front and back load of the heart.
4. Improve myocardial metabolism, reduce the resistance of the coronary arteries, and increase the oxygen supply of the myocardium.
5. It has the effect of inhibiting platelet aggregation and protecting cardiovascular.
6. Meglumine also has an antiarrhythmic effect. Mainly used for the treatment of acute and chronic heart failure, coronary heart disease, cardiomyopathy, myocarditis, sick sinus syndrome and other diseases.
7. Meglumine is an organic base which is mainly used as a pH adjuster and solubilizer in the preparation of a soluble salt of an iodinated organic acid (used as an X-ray contrast agent).
